insights_auto
Why is STIM down 2.80%?
Dive Deeperchevron_right
STIM:NASDAQ
Neuronetics Inc
$1.39
arrow_downward
-2.80%(-0.040) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$1.21
High
$1.44
Low
$1.20
Mkt. cap
108.04M
Avg. vol.
1.63M
Volume
16.26M
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.33
Beta
1.36
Shares outstanding
77.73M
No. of employees
658
Open
$1.21
High
$1.44
Low
$1.20
Mkt. cap
108.04M
Avg. vol.
1.63M
Volume
16.26M
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.33
Beta
1.36
Shares outstanding
77.73M
No. of employees
658
News stories
From web sources and news partners
Investing.com India
·
1 day ago
Neuronetics director Jorey Chernett sells $4.48 million in stock By Investing.com
TradingView
·
2 days ago
Neuronetics - Offering 18,750,000 Shares Of Common Stock - SEC Filing
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorHealth Care
IndustryMedical device
Websiteneurostar.com